{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:38:28Z","timestamp":1792607908749,"version":"4.5.0"},"reference-count":51,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"National Natural Science Foundations of China","award":["82272211"],"award-info":[{"award-number":["82272211"]}]},{"name":"National Natural Science Foundations of China","award":["82572527"],"award-info":[{"award-number":["82572527"]}]},{"name":"General Natural Science Foundation of Jiangsu Province","award":["BK20252100"],"award-info":[{"award-number":["BK20252100"]}]},{"name":"Jiangsu Province High-Level Hospital Pairing Assistance Construction Funds","award":["zdyyxy29"],"award-info":[{"award-number":["zdyyxy29"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Intensive Care Med"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies showed different results of vasopressors combination therapy in septic shock patients. This meta-analysis aimed to evaluate the outcomes of combination of norepinephrine plus vasopressin receptor agonists in adult septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cochrane Library, Embase, Web of Science, and PubMed databases were searched up to September 27, 2026, to identify randomized controlled trials (RCTs) comparing the combination of norepinephrine plus vasopressin receptor agonists versus norepinephrine alone in septic shock patients. Two reviewers independently extracted data on mortality, ICU length of stay, renal replacement therapy (RRT) and adverse events. Trial sequential analysis (TSA) was applied to assess random error.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-one RCTs involving 3873 septic shock patients were included. The results showed that the combination of norepinephrine plus vasopressin receptor agonists was associated with lower mortality at the longest complete follow-up compared with norepinephrine alone (RR\u2009=\u20090.90, 95% CI 0.83 to 0.99,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02), but with an increased risk of digital ischemia (RR\u2009=\u20092.21, 95% CI 1.15 to 4.27,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02). Subgroup analysis indicated that the combination of norepinephrine plus vasopressin receptor agonists may provide survival benefits for more severe septic shock patients (RR\u2009=\u20090.90, 95% CI 0.81 to 1.00,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.04). Moreover, compared with norepinephrine alone, the combination of norepinephrine plus vasopressin showed a trend towards reducing the longest follow-up mortality (RR\u2009=\u20090.89, 95% CI 0.80 to 1.00,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.05). TSA indicated lack of firm evidence for a beneficial effect.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In adults with septic shock, the combination of norepinephrine plus vasopressin receptor agonists may reduce mortality at the longest complete follow-up compared with norepinephrine alone (low quality of evidence), but may increase risk of digital ischemia (low quality of evidence). This benefit mainly appeared in more severe septic shock patients. Moreover, norepinephrine plus vasopressin may confer a survival advantage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08850666261500019","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:08:43Z","timestamp":1792422523000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Vasopressors Combination Therapy (Norepinephrine Plus Vasopressin Receptor Agonists) Improve Septic Shock Outcome: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8615-4646","authenticated-orcid":false,"given":"Weijie","family":"Yu","sequence":"first","affiliation":[{"name":"Southeast University","place":["P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6381-7523","authenticated-orcid":false,"given":"Yanjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Southeast University","place":["P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6467-8043","authenticated-orcid":false,"given":"Zhu","family":"Luo","sequence":"additional","affiliation":[{"name":"Southeast University","place":["P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4791-2421","authenticated-orcid":false,"given":"Xiner","family":"Cai","sequence":"additional","affiliation":[{"name":"Southeast University","place":["P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8979-2416","authenticated-orcid":false,"given":"Jiyue","family":"Shao","sequence":"additional","affiliation":[{"name":"Southeast University","place":["P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9231-6370","authenticated-orcid":false,"given":"Wanting","family":"Lin","sequence":"additional","affiliation":[{"name":"Southeast University","place":["P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1240-4929","authenticated-orcid":false,"given":"Jingyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Southeast University","place":["P.R. China"]},{"name":"Southeast University","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7885"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005357"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07332-8"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2045-8"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000333"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067373"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-0628-2"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05669-0"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4528"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2362-4"},{"issue":"4","key":"e_1_3_4_13_2","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials","volume":"16","author":"Neto AS","year":"2012","unstructured":"Neto AS, Nassar AP, Cardoso SO, et al. Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials. Crit Care. 2012;16(4):R154.","journal-title":"Crit Care"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00563"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000002558"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05620-2"},{"key":"e_1_3_4_17_2","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.4","author":"Higgins JPT","year":"2024","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.4. Cochrane; 2024."},{"key":"e_1_3_4_18_2","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Br Med J. 2021;372:n71.","journal-title":"Br Med J"},{"key":"e_1_3_4_19_2","unstructured":"Cochrane RoB 2. A Revised Cochrane Risk-of-Bias Tool for Randomized Trials. Available online: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Accessed 25 Nov 2025."},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/09622802231172043"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1429"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705835"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05422-7"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0261-x"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"issue":"1","key":"e_1_3_4_31_2","first-page":"15","article-title":"The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: Microcirculation, is it the black box?","volume":"54","author":"Barzegar E","year":"2016","unstructured":"Barzegar E, Ahmadi A, Mousavi S, Nouri M, Mojtahedzadeh M. The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: Microcirculation, is it the black box? Acta Med Iran. 2016;54(1):15-23.","journal-title":"Acta Med Iran"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000066692.71008.BB"},{"issue":"2","key":"e_1_3_4_33_2","first-page":"114","article-title":"Uso de vasopresina en pacientes con choque s\u00e9ptico refractario a catecolaminas","volume":"13","author":"Fonseca-Ruiz N","year":"2013","unstructured":"Fonseca-Ruiz N, Lemos Cano A, Ortiz Carmona PD, et al. Uso de vasopresina en pacientes con choque s\u00e9ptico refractario a catecolaminas. Acta Colombiana de Cuidado Intensivo. 2013;13(2):114-123.","journal-title":"Acta Colombiana de Cuidado Intensivo"},{"issue":"3","key":"e_1_3_4_34_2","first-page":"58","article-title":"Comparison between norepinephrine alone versus norepinephrine\/vasopressin combination for resuscitation in septic shock A randomized clinical trial","volume":"8","author":"Hussien RM","year":"2021","unstructured":"Hussien RM, El-Gendy HA, Elsaidy MI, Abdelhamid MS, Shabana TS. Comparison between norepinephrine alone versus norepinephrine\/vasopressin combination for resuscitation in septic shock A randomized clinical trial. Egypt. J. Critical. Care. Med. 2021;8(3):58-65.","journal-title":"Egypt. J. Critical. Care. Med"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.14607"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usae369"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen017"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc13348"},{"key":"e_1_3_4_39_2","first-page":"138A","article-title":"Early introduction of a combination of low dose terlipressin and noradrenaline as vasopressors is superior to high dose noradrenaline alone in patients of cirrhosis with septic shock","volume":"66","author":"Prakash V","year":"2017","unstructured":"Prakash V, Choudhury AK, Sarin SK. Early introduction of a combination of low dose terlipressin and noradrenaline as vasopressors is superior to high dose noradrenaline alone in patients of cirrhosis with septic shock. Hepatology (Baltimore, Md.). 2017;66:138A.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1798-7"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-24231"},{"issue":"116","key":"e_1_3_4_42_2","first-page":"1043","article-title":"Terlipressin in the treatment of late phase catecholamine-resistant septic shock","volume":"59","author":"Svoboda P","year":"2012","unstructured":"Svoboda P, Scheer P, Kantorov\u00e1 I, et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepatogastroenterology. 2012;59(116):1043-1047.","journal-title":"Hepatogastroenterology"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2022.2095286"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2015.07.016"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10485"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0378-0"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5267-9"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199910000-00014"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(26)00596-9"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05401-y"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.3046"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13252"}],"container-title":["Journal of Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666261500019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08850666261500019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666261500019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:48:58Z","timestamp":1792604938000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08850666261500019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":51,"alternative-id":["10.1177\/08850666261500019"],"URL":"https:\/\/doi.org\/10.1177\/08850666261500019","relation":{},"ISSN":["0885-0666","1525-1489"],"issn-type":[{"value":"0885-0666","type":"print"},{"value":"1525-1489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"article-number":"08850666261500019"}}